Korean patent office follows JPTO, USPTO, CIPO and INPI (Brazil) with which INPI already has a PPH agreement
This decision concerns the appeal filed by the opponent (appellant) against the opposition division's interlocutory decision which held the European patent in an amended form.
Claim 1 of the main…
European patent No. 2 522 717 is based on European patent application No. 12 160 789.9, entitled "Oligopeptide-free cell culture media", filed as a divisional application of the earlier European…
Montenegro loses its status of extension state and becomes, as of 01/10/2022, a new full member of the EPC, bringing the number of EPC member states to 39.
European patent 2 451 486 ("the patent") was granted with independent claim 1 relating to:
"A conjugate for use in medicine, the conjugate comprising an L-asparaginase from Erwinia chrysanthemi…
Appeals have been filed by the opponent and the patent proprietor against the opposition division’s interlocutory decision to maintain European patent No. 2 170 949 in amended form according to…
Commission Regulation (EU) 2022/720 of 10 May 2022 enters into force on 01/06/2022 to replace Regulation (EU) 330/2010.
See press release here
European patent 2 790 657 was granted with claim 1 as follows:
"1. Cosmetic composition for coating keratinous fibres of the emulsion type, comprising:
- an aqueous phase,
- at least one wax, and
…
The European patent No. 2 322 153 was granted with a set of 11 claims. Claim 1 as granted reads as follows:
1. A compound that inhibits hypoxia inducible factor (HIF) hydroxylase activity for use in…
The appeal by the patent proprietor lies against the decision of the opposition division revoking European patent No. 2 686 382.
Claim 1 of the main request reads as follows:
"1. Propylene…